In support of these findings, it has been demonstrated that mucosal BCG vaccination, as well as the CAF01-adjuvanted fusion protein Ag85B-ESAT6, induces an antigen specific KLRG1- CD4+ T cell population, which confers better protection against tuberculosis (41, 42). Here, CD4 is linked to tuberculosis.